Works by Knop, Stefan

Results: 68
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 2, p. 377, doi. 10.1080/10428194.2019.1666381
    By:
    • Ludwig, Heinz;
    • Pönisch, Wolfram;
    • Knop, Stefan;
    • Egle, Alexander;
    • Hinke, Axel;
    • Schreder, Martin;
    • Lechner, Daniel;
    • Hajek, Roman;
    • Gunsilius, Eberhard;
    • Petzer, Andreas;
    • Weisel, Katja;
    • Niederwieser, Dietger;
    • Einsele, Hermann;
    • Willenbacher, Wolfgang;
    • Rumpold, Holger;
    • Pour, Ludek;
    • Jelinek, Tomas;
    • Krenosz, Karl Jochen;
    • Meckl, Angela;
    • Nolte, Sandra
    Publication type:
    Article
    10
    11

    In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.

    Published in:
    EMBO Molecular Medicine, 2015, v. 7, n. 4, p. 477, doi. 10.15252/emmm.201404698
    By:
    • Philipp‐Abbrederis, Kathrin;
    • Herrmann, Ken;
    • Knop, Stefan;
    • Schottelius, Margret;
    • Eiber, Matthias;
    • Lückerath, Katharina;
    • Pietschmann, Elke;
    • Habringer, Stefan;
    • Gerngroß, Carlos;
    • Franke, Katharina;
    • Rudelius, Martina;
    • Schirbel, Andreas;
    • Lapa, Constantin;
    • Schwamborn, Kristina;
    • Steidle, Sabine;
    • Hartmann, Elena;
    • Rosenwald, Andreas;
    • Kropf, Saskia;
    • Beer, Ambros J;
    • Peschel, Christian
    Publication type:
    Article
    12
    13
    14
    15

    Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

    Published in:
    Frontiers in Hematology, 2024, p. 1, doi. 10.3389/frhem.2024.1436845
    By:
    • Leitner, Theo;
    • Shumilov, Evgenii;
    • Schwitlick, Christina;
    • Koch, Raphael;
    • Hamm, Franziska;
    • Högner, Marion;
    • Bassermann, Florian;
    • Weisel, Katja;
    • Einsele, Hermann;
    • Kortüm, Martin;
    • Rasche, Leo;
    • Görner, Martin;
    • Wegehenkel, Kai;
    • Knop, Stefan;
    • Krönke, Jan;
    • Nogai, Axel;
    • König, Inke R.;
    • Vens, Maren;
    • Horn, Kay;
    • von Bubnoff, Nikolas
    Publication type:
    Article
    16
    17

    Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005
    By:
    • Mateos, Maria-Victoria;
    • Dimopoulos, Meletios A.;
    • Cavo, Michele;
    • Suzuki, Kenshi;
    • Knop, Stefan;
    • Doyen, Chantal;
    • Lucio, Paulo;
    • Nagy, Zsolt;
    • Pour, Ludek;
    • Grosicki, Sebastian;
    • Crepaldi, Andre;
    • Liberati, Anna Marina;
    • Campbell, Philip;
    • Yoon, Sung-Soo;
    • Iosava, Genadi;
    • Fujisaki, Tomoaki;
    • Garg, Mamta;
    • Iida, Shinsuke;
    • Bladé, Joan;
    • Ukropec, Jon
    Publication type:
    Article
    18

    P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2
    By:
    • Lonial, Sagar;
    • Berdeja, Jesus G.;
    • Dimopoulos, Meletios-Athanasios;
    • Jagannath, Sundar;
    • Knop, Stefan;
    • Hang Quach;
    • Rodríguez-Otero, Paula;
    • Richardson, Paul G.;
    • Sorrell, April;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • Tuong Vi Nguyen;
    • Hong, Kevin;
    • Peluso, Teresa;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    19

    OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
    By:
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Popat, Rakesh;
    • Stadtmauer, Edward A.;
    • Larsen, Jeremy T.;
    • Oriol, A.;
    • Knop, Stefan;
    • Jagannath, Sundar;
    • Cook, Gordon;
    • Badros, Ashraf Z.;
    • Rodríguez-Otero, Paula;
    • Siegel, David S.;
    • Tuong Vi Nguyen;
    • Micco, Antonia Di;
    • Amin, Alpesh;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5215, doi. 10.1007/s10238-023-01100-6
    By:
    • Bittrich, Max;
    • Hetterich, Regina;
    • Solimando, Antonio G.;
    • Krebs, Markus;
    • Loda, Sophia;
    • Danhof, Sophia;
    • Anton, Straub;
    • Zhou, Xiang;
    • Kerscher, Alexander;
    • Beilhack, Andreas;
    • Kortüm, K. Martin;
    • Rasche, Leo;
    • Einsele, Hermann;
    • Knop, Stefan;
    • Hartmann, Stefan
    Publication type:
    Article
    28

    Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.

    Published in:
    European Journal of Haematology, 2019, v. 103, n. 3, p. 255, doi. 10.1111/ejh.13281
    By:
    • Straka, Christian;
    • Knop, Stefan;
    • Vogel, Martin;
    • Müller, Jürgen;
    • Kropff, Martin;
    • Metzner, Bernd;
    • Langer, Christian;
    • Sayer, Herbert;
    • Jung, Wolfram;
    • Dürk, Heinz A.;
    • Salwender, Hans;
    • Wandt, Hannes;
    • Bassermann, Florian;
    • Gramatzki, Martin;
    • Rösler, Wolf;
    • Wolf, Hans‐Heinrich;
    • Brugger, Wolfram;
    • Fischer, Thomas;
    • Liebisch, Peter;
    • Engelhardt, Monika
    Publication type:
    Article
    29
    30

    Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.

    Published in:
    European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
    By:
    • Straka, Christian;
    • Salwender, Hans;
    • Knop, Stefan;
    • Vogel, Martin;
    • Müller, Jürgen;
    • Metzner, Bernd;
    • Langer, Christian;
    • Sayer, Herbert;
    • Jung, Wolfram;
    • Dürk, Heinz A.;
    • Bassermann, Florian;
    • Gramatzki, Martin;
    • Rösler, Wolf;
    • Wolf, Hans‐Heinrich;
    • Brugger, Wolfram;
    • Engelhardt, Monika;
    • Fischer, Thomas;
    • Liebisch, Peter;
    • Einsele, Hermann
    Publication type:
    Article
    31

    First-in-Human Experience of CXCR4-Directed Endoradiotherapy with <sup>177</sup>Lu- and <sup>90</sup>Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 248, doi. 10.2967/jnumed.115.167361
    By:
    • Herrmann, Ken;
    • Schottelius, Margret;
    • Lapa, Constantin;
    • Osl, Theresa;
    • Poschenrieder, Andreas;
    • Hänscheid, Heribert;
    • Lückerath, Katharina;
    • Schreder, Martin;
    • Bluemel, Christina;
    • Knott, Markus;
    • Keller, Ulrich;
    • Schirbel, Andreas;
    • Samnick, Samuel;
    • Lassmann, Michael;
    • Kropf, Saskia;
    • Buck, Andreas K.;
    • Einsele, Hermann;
    • Wester, Hans-Juergen;
    • Knop, Stefan
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Targeted sequencing using a 47 gene multiple myeloma mutation panel (M<sup>3</sup>P) in -17p high risk disease.

    Published in:
    British Journal of Haematology, 2015, v. 168, n. 4, p. 507, doi. 10.1111/bjh.13171
    By:
    • Kortüm, Klaus M.;
    • Langer, Christian;
    • Monge, Jorge;
    • Bruins, Laura;
    • Egan, Jan B.;
    • Zhu, Yuan X.;
    • Shi, Chang Xin;
    • Jedlowski, Patrick;
    • Schmidt, Jessica;
    • Ojha, Juhi;
    • Bullinger, Lars;
    • Liebisch, Peter;
    • Kull, Miriam;
    • Champion, Mia D.;
    • Van Wier, Scott;
    • Ahmann, Gregory;
    • Rasche, Leo;
    • Knop, Stefan;
    • Fonseca, Rafael;
    • Einsele, Hermann
    Publication type:
    Article
    38
    39
    40

    AA amyloidosis in inflammatory active malignant paraganglioma.

    Published in:
    Amyloid, 2022, v. 29, n. 2, p. 137, doi. 10.1080/13506129.2021.2016691
    By:
    • Ihne, Sandra;
    • Kircher, Malte;
    • Papagianni, Aikaterini;
    • Goetze, Oliver;
    • Morbach, Caroline;
    • Werner, Rudolf A.;
    • Zeller, Daniel;
    • Sommer, Claudia;
    • Rosenwald, Andreas;
    • Amann, Kerstin;
    • Linke, Reinhold P.;
    • Lapa, Constantin;
    • Einsele, Hermann;
    • Geier, Andreas;
    • Obici, Laura;
    • Palladini, Giovanni;
    • Knop, Stefan;
    • Störk, Stefan
    Publication type:
    Article
    41
    42
    43

    Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 10, p. 1694, doi. 10.1007/s00259-018-3997-0
    By:
    • Stolzenburg, Antje;
    • Lückerath, Katharina;
    • Samnick, Samuel;
    • Speer, Martin;
    • Kneer, Katharina;
    • Schmid, Jan-Stefan;
    • Grigoleit, Götz Ulrich;
    • Hofmann, Susanne;
    • Beer, Ambros J.;
    • Bunjes, Donald;
    • Knop, Stefan;
    • Buck, Andreas K.;
    • Einsele, Hermann;
    • Lapa, Constantin
    Publication type:
    Article
    44
    45
    46
    47

    Kardiale Amyloidose.

    Published in:
    Medizinische Klinik (Urban & Vogel), 2008, v. 103, n. 3, p. 153
    By:
    • Christiane Angermann;
    • Stefan Knop;
    • Georg Ertl;
    • Stefan Störk
    Publication type:
    Article
    48

    Cardio-Hepatic Interaction in Cardiac Amyloidosis.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1440, doi. 10.3390/jcm13051440
    By:
    • Ihne-Schubert, Sandra Michaela;
    • Goetze, Oliver;
    • Gerstendörfer, Felix;
    • Sahiti, Floran;
    • Schade, Ina;
    • Papagianni, Aikaterini;
    • Morbach, Caroline;
    • Frantz, Stefan;
    • Einsele, Hermann;
    • Knop, Stefan;
    • Sommer, Claudia;
    • Müllhaupt, Beat;
    • Schubert, Torben;
    • Störk, Stefan;
    • Geier, Andreas
    Publication type:
    Article
    49
    50